Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000802811 | SCV000942656 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000802811 | SCV002793818 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2022-04-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003411766 | SCV004113289 | uncertain significance | AIRE-related disorder | 2022-11-23 | criteria provided, single submitter | clinical testing | The AIRE c.1169C>T variant is predicted to result in the amino acid substitution p.Thr390Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-45712949-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Natera, |
RCV000802811 | SCV002083899 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-02-21 | no assertion criteria provided | clinical testing |